Sword Health

Headquarters: USA

Filing date: 2026-01-10

Estimated valuation: $800.0M

Executive Summary

Sword Health is a top company in the field of digital bone and muscle therapy. It uses its Phoenix AI software and high-quality motion sensors to help more than 3,000 corporate customers. The business earns about 400 million dollars in yearly sales while losing a relatively small 25 million dollars after expenses. It focuses more on growing its market share right now than on making a profit immediately. A recent valuation of 3 billion dollars shows that investors believe the company is strong as it prepares to sell shares on the public market and grow its automatic movement-tracking tools. Sword has an advantage over rivals because it owns a massive amount of medical data. However, it faces risks from new government rules and changes in how insurance companies pay for health care that uses artificial intelligence. By selling to companies that provide health insurance for employees, the platform tries to lower the cost of surgery and change how money is spent on long-term pain. This public stock offering will be a major test to see if AI-run health services can actually make money and grow over time. If the plan works, Sword could move billions in medical spending away from hospitals and toward digital health treatments.

Risk Analysis

Detailed risk factors, AI-graded risk score, financials, and analyst commentary for Sword Health are available to Pro subscribers.

Unlock the full report or browse 500+ pre-IPO prospects.